S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
OTCMKTS:ACOPF

a2 Milk - ACOPF Price Target & Analyst Ratings

$3.70
-0.13 (-3.39%)
(As of 09/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.70
▼
$3.84
50-Day Range
$2.97
▼
$3.84
52-Week Range
$2.75
▼
$5.44
Volume
8,000 shs
Average Volume
3,946 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

a2 Milk Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Reduce
Based on 2 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
9/8/21 to 9/8/22		1 Month Ago
8/9/21 to 8/9/22		3 Months Ago
6/10/21 to 6/10/22		1 Year Ago
9/8/20 to 9/8/21
Consensus Rating
Reduce
Hold
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/A$7.20$7.20$7.20
Predicted UpsideN/A67.44% Upside67.44% Upside67.44% Upside
Get a2 Milk Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACOPF and its competitors with MarketBeat's FREE daily newsletter.


ACOPF Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACOPF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

a2 Milk Stock vs. The Competition

Typea2 MilkConsumer Defensive CompaniesS&P 500
Consensus Rating Score
1.00
2.43
2.49
Consensus RatingReduceHoldHold
Predicted Upside112.19% Upside21.72% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating		 Outperform Votes
4
57.14%
Underperform Votes
3
42.86%
Avg. Outperform Votes
111
62.36%
Avg. Underperform Votes
67
37.64%
Avg. Outperform Votes
851
68.46%
Avg. Underperform Votes
392
31.54%

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/8/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageSell
6/13/2022CLSA
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Underperform
8/30/2021Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Buy$7.20+67.44%
2/22/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderweight ➝ Neutral
(Data available from 9/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ACOPF Price Target - Frequently Asked Questions

What is a2 Milk's consensus rating?

According to the issued ratings of 2 analysts in the last year, the consensus rating for a2 Milk stock is Reduce based on the current 2 sell ratings for ACOPFthe . Learn more on ACOPF's analyst rating history.

Do Wall Street analysts like a2 Milk more than its competitors?

Analysts like a2 Milk less than other Consumer Defensive companies. The consensus rating for a2 Milk is Reduce while the average consensus rating for consumer defensive companies is Hold. Learn more on how ACOPF compares to other companies.

Do MarketBeat users like a2 Milk more than its competitors?

MarketBeat users like a2 Milk less than other Consumer Defensive companies. 57.14% of MarketBeat users gave a2 Milk an outperform vote while consumer defensive companies recieve an average of 62.36% outperform votes by MarketBeat users.

Is a2 Milk being downgraded by Wall Street analysts?

Over the previous 90 days, a2 Milk's stock had 1 downgrade by analysts.

What analysts cover a2 Milk?

a2 Milk has been rated by CLSA, and The Goldman Sachs Group in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (OTCMKTS:ACOPF) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.